| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/11/2007 | CN1944428A Chroman compound and its preparing method and use in producing medicine |
| 04/11/2007 | CN1944424A Aryl formyl piperazine compound and its preparing method and use in medicine production |
| 04/11/2007 | CN1944416A Benzimidazole compound and its preparing method and use in medicine production |
| 04/11/2007 | CN1944404A Indolyl alkyl-amine compounds and their preparing method and use in medicine production |
| 04/11/2007 | CN1943790A Prevention and treatment of restenosis by local administration of drug |
| 04/11/2007 | CN1943786A Ester compound and its medicinal application |
| 04/11/2007 | CN1943781A Orally administered peptides to ameliorate atherosclerosis |
| 04/11/2007 | CN1943776A The onion blood pressure decreasing capsule, oral liquid, tablet and their preparation method |
| 04/11/2007 | CN1943771A The pharmaceutical for treatment of vascular lesion through actions on the NEI network |
| 04/11/2007 | CN1943769A An external pharmaceutical for treatment of arrhythmia, coronary heart disease and angina pectoris |
| 04/11/2007 | CN1943768A A Chinese traditional medicine for treatment of hemorrhoid, anal fistula and anal fissure and their preparation methods |
| 04/11/2007 | CN1943756A A Chinese traditional medicinal composite used for treatment of hypertension and its preparation method |
| 04/11/2007 | CN1943755A A Chinese traditional medicinal composition for treatment of hypertension and its preparation method |
| 04/11/2007 | CN1943751A A health-protective pharmaceutical for activating and improving intellect and its preparation method |
| 04/11/2007 | CN1943726A A Chinese traditional medicinal composition for treatment of ischemic apoplexy and its preparation method |
| 04/11/2007 | CN1943718A A Chinese traditional medicinal composition and its preparation method |
| 04/11/2007 | CN1943717A A Chinese traditional medicinal composition for treatment of low blood pressure and its preparation method |
| 04/11/2007 | CN1943715A A Chinese traditional medicinal injection preparation and its preparation method |
| 04/11/2007 | CN1943710A The application of radix ophioponis in the medicines for treating myocarditis and medicines containing its extracts with active elements |
| 04/11/2007 | CN1943673A Sedation brain refreshing liquid |
| 04/11/2007 | CN1943649A A Chinese traditional medicine preparation for treating chest numb cardiodynia and its preparing method |
| 04/11/2007 | CN1943643A A Chinese traditional medicinal preparation for treating cardiovascular stasis coronary heart disease and its preparing method |
| 04/11/2007 | CN1943627A Chinese medicine composition for treating ischemic apoplexy and its preparing method |
| 04/11/2007 | CN1943622A Method for preparing Chinese medicine particles for treating cardio-cerebral vascular diseases and its product |
| 04/11/2007 | CN1943621A Chinese medicine composition for treating apoplexy and its preparing method |
| 04/11/2007 | CN1943620A Chinese medicine composition for treating cardio-cerabral vascular diseases and its preparing method |
| 04/11/2007 | CN1943618A Red sage root effective part standard extract and its preparing method and use |
| 04/11/2007 | CN1943602A Bee pollen bee glue composition and its preparing method |
| 04/11/2007 | CN1943585A Breviscapine proliposome powder preparation and its preparing method |
| 04/11/2007 | CN1943584A Medicinal composition for treating cardio-cerebral vascular disease and its preparing method |
| 04/11/2007 | CN1943583A Freeze-dried preparation for treating cerebral vascular disease |
| 04/11/2007 | CN1943571A Butylphthalide dripping pill and preparing method |
| 04/11/2007 | CN1943569A Chinese medicine active component composition and its preparing method and use |
| 04/11/2007 | CN1943564A Indapamide slow release tablet and its preparing method |
| 04/11/2007 | CN1309833C Angiostatin and its use for preparing medicament |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309813C Oil or fat composition |
| 04/11/2007 | CN1309760C Poly asparaginyl aminoacetic acid, alanine and lysine and its preparation method and medicament purpose |
| 04/11/2007 | CN1309721C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety |
| 04/11/2007 | CN1309720C Piperazine compounds |
| 04/11/2007 | CN1309710C Pyrimidine derivitive |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309703C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309409C Chinese medicine composite for treatment and prevention of cerebral arteries obstruction |
| 04/11/2007 | CN1309404C Hypertension treating medicine capable of protecting target organ and its production process |
| 04/11/2007 | CN1309398C Orally disintegrating tablet for treating cardiovascular diseases and its preparing process |
| 04/11/2007 | CN1309397C Compound red sage capsule for treating cardiac and cerebral vascular diseases and its prepn process |
| 04/11/2007 | CN1309389C Combination of inhibiting activity of acetylcholinesterase, preparation method and application |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/11/2007 | CN1309377C Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 04/11/2007 | CN1309376C Musk slow-controlled release preparation and preparation method thereof |
| 04/11/2007 | CN1309369C Maluoning powder injection for injection and its preparing method |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202344 An antibody or fragment (especially a monoclonal antibody) that binds to specific antigens for use in the diagnosis and treatment of heart, kidney and inflammatory diseases |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202274 Cyclic hemiacetal derivative and use thereof |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202247 Such as 4-(3-(2,4-dimethoxy-5-thiophen-2-yl-phenyl)-propynoyl)-benzoic acid methyl ester; for inhibiting expression of vascular cellular adhesion molecules |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202065 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7202053 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 04/10/2007 | US7202052 Regulatory protein for use in induction of nicotinamide adenine dinucleotide oxidase (NOX) for use as free radical quencher in prevention and treatment of cardiovascular and cell proliferative disorders |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/10/2007 | US7201892 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 04/10/2007 | CA2470066C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2377746C N-pyrazole a2a receptor agonists |
| 04/10/2007 | CA2364199C Novel bicyclic derivatives of aminopyrazinone, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2323151C Biodegradable polymer/protein based coils for intralumenal implants |
| 04/10/2007 | CA2269807C Substituted aminoalkanephosphonic acids |
| 04/10/2007 | CA2177772C Pharmaceutical compositions containing irbesartan |
| 04/10/2007 | CA2170739C Method to reduce myocardial injury during acute myocardial infarction |
| 04/10/2007 | CA2162306C Use of dl-(+/-)-.alpha.-lipoic acid, d-(+)-.alpha.-lipoic acid, .alpha. lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 04/10/2007 | CA2153937C Tricyclic pyrazole derivatives |
| 04/10/2007 | CA2148194C Cyclopeptides of the formula i |
| 04/10/2007 | CA2102447C Cyclopeptides |
| 04/05/2007 | WO2007038074A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 04/05/2007 | WO2007037788A1 Antibody composition and passive immunization against pregnancy-induced hypertension using antidigoxin antibody (digibind) |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007037438A1 Ameliorating agent for metabolic syndrome |
| 04/05/2007 | WO2007037299A1 Substance inhibiting the expression of hb24 or the transcriptional regulatory activity thereof, use of the same and method of screening the substance |
| 04/05/2007 | WO2007037297A1 Composition effective for prevention and treatment of adult disease |
| 04/05/2007 | WO2007037245A1 Polypeptide having anti-angiogenic activity |
| 04/05/2007 | WO2007036781A1 Diphenyl ether monoamine reuptake inhibitor |
| 04/05/2007 | WO2007036041A1 Sialidase inhibitors for the treatment of cardiovascular disease |
| 04/05/2007 | WO2007015003A3 Novel crystalline iii form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |